...
首页> 外文期刊>Molecules >Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
【24h】

Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation

机译:新型他克林-黄cut苷杂化物作为多能抗阿尔茨海默病病原体的设计,合成和生物学评估

获取原文
           

摘要

A novel series of 6-chlorotacrine-scutellarin hybrids was designed, synthesized and the biological activity as potential anti-Alzheimer’s agents was assessed. Their inhibitory activity towards human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBChE), antioxidant activity, ability to cross the blood-brain barrier (BBB) and hepatotoxic profile were evaluated in vitro. Among these compounds, hybrid K1383, bearing two methylene tether between two basic scaffolds, was found to be very potent hAChE inhibitor (IC50 = 1.63 nM). Unfortunately, none of the hybrids displayed any antioxidant activity (EC50 ≥ 500 μM). Preliminary data also suggests a comparable hepatotoxic profile with 6-Cl-THA (established on a HepG2 cell line). Kinetic studies performed on hAChE with the most active compound in the study, K1383, pointed out to a mixed, non-competitive enzyme inhibition. These findings were further corroborated by docking studies. View Full-Text
机译:设计,合成了一系列新型的6-氯他克林-黄cut苷杂种,并评估了其作为潜在抗阿尔茨海默病药物的生物学活性。在体外评估了它们对人乙酰胆碱酯酶(hAChE)和人丁酰胆碱酯酶(hBChE)的抑制活性,抗氧化活性,穿过血脑屏障的能力和肝毒性。在这些化合物中,发现在两个基本支架之间带有两个亚甲基系链的杂合K1383是非常有效的hAChE抑制剂(IC50 = 1.63 nM)。不幸的是,没有一个杂种表现出任何抗氧化活性(EC50≥500μM)。初步数据还表明,可与6-Cl-THA(在HepG2细胞系上建立)的肝毒性特征进行比较。用研究中活性最高的化合物K1383对hAChE进行的动力学研究指出了混合的,非竞争性的酶抑制作用。对接研究进一步证实了这些发现。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号